Regulatory Considerations for 21st Century Paperless Trials.
- Published in:
- Applied Clinical Trials, 2017, v. 26, n. 4/5, p. 25
- By:
- Publication type:
- Article
Works matching IS 10648542 AND DT 2017 AND VI 26 AND IP 4/5
Results: 22
1
2
Ethics Under the Clinical Trials Regulation.
- Published in:
- Applied Clinical Trials, 2017, v. 26, n. 4/5, p. 42
- By:
- Publication type:
- Article
3
Malaysia's Clinical Research Ecosystem.
- Published in:
- Applied Clinical Trials, 2017, v. 26, n. 4/5, p. 36
- By:
- Publication type:
- Article
4
The Regulatory Debate Around Pre-approval Product Access.
- Published in:
- Applied Clinical Trials, 2017, v. 26, n. 4/5, p. 30
- By:
- Publication type:
- Article
5
Outsourcing: Playing to Win.
- Published in:
- Applied Clinical Trials, 2017, v. 26, n. 4/5, p. 20
- By:
- Publication type:
- Article
6
BRACKET ACQUIRED BY PRIVATE EQUITY FIRM.
- Published in:
- Applied Clinical Trials, 2017, v. 26, n. 4/5, p. 19
- Publication type:
- Article
7
FDA REFINES INSPECTION PROCESS FOR CLINICAL SITES.
- Published in:
- Applied Clinical Trials, 2017, v. 26, n. 4/5, p. 18
- By:
- Publication type:
- Article
8
SURVEY EXAMINES THE STATE OF eCONSENT.
- Published in:
- Applied Clinical Trials, 2017, v. 26, n. 4/5, p. 18
- By:
- Publication type:
- Article
9
REDUCING THE DATA BURDEN FOR CLINICAL INVESTIGATORS.
- Published in:
- Applied Clinical Trials, 2017, v. 26, n. 4/5, p. 17
- By:
- Publication type:
- Article
10
EUROPEAN REFERENCE NETWORKS RECOGNIZED.
- Published in:
- Applied Clinical Trials, 2017, v. 26, n. 4/5, p. 16
- By:
- Publication type:
- Article
11
SQUEEZING DRUG AUTHORIZATION AT BOTH ENDS.
- Published in:
- Applied Clinical Trials, 2017, v. 26, n. 4/5, p. 16
- By:
- Publication type:
- Article
12
FDA PROMOTES DIVERSITY IN CLINICAL TRIALS.
- Published in:
- Applied Clinical Trials, 2017, v. 26, n. 4/5, p. 15
- By:
- Publication type:
- Article
13
GOTTLIEB TO FACE USER FEES, DE REGULATION PRESSURES.
- Published in:
- Applied Clinical Trials, 2017, v. 26, n. 4/5, p. 14
- By:
- Publication type:
- Article
14
THE ELUSIVE GOAL OF OPTIMIZING DEVELOPMENT OPERATIONS.
- Published in:
- Applied Clinical Trials, 2017, v. 26, n. 4/5, p. 12
- By:
- Publication type:
- Article
15
IDMP: AN INTERNATIONAL STANDARD FOR LIFECYCLE DATA MANAGEMENT.
- Published in:
- Applied Clinical Trials, 2017, v. 26, n. 4/5, p. 10
- By:
- Publication type:
- Article
16
COLLABORATION ON EU'S NEW CLINICAL TRIALS RULE BRINGS OPPORTUNITY, CHALLENGES.
- Published in:
- Applied Clinical Trials, 2017, v. 26, n. 4/5, p. 9
- By:
- Publication type:
- Article
17
EMA NOTES.
- Published in:
- Applied Clinical Trials, 2017, v. 26, n. 4/5, p. 8
- Publication type:
- Article
18
WHAT'S NEW IN THE 'NEW' EU PERSONALIZED MEDICINES BID?
- Published in:
- Applied Clinical Trials, 2017, v. 26, n. 4/5, p. 8
- By:
- Publication type:
- Article
19
FDA NOTES.
- Published in:
- Applied Clinical Trials, 2017, v. 26, n. 4/5, p. 7
- Publication type:
- Article
20
ORPHAN DRUG SURGE RAISES REGULATORY AND DEVELOPMENT CHALLENGES.
- Published in:
- Applied Clinical Trials, 2017, v. 26, n. 4/5, p. 7
- By:
- Publication type:
- Article
21
EFGCP PUTS RENEWED EMPHASIS ON COMPLEX STUDIES.
- Published in:
- Applied Clinical Trials, 2017, v. 26, n. 4/5, p. 6
- By:
- Publication type:
- Article
22
Choose Consistency Over Chaos.
- Published in:
- Applied Clinical Trials, 2017, v. 26, n. 4/5, p. 3
- By:
- Publication type:
- Article